title: Fournier's gangrene--current concepts.
abstract: Fournier's gangrene (FG) is a rapidly progressive form of infective necrotising fasciitis of the perineal, genital, or perianal regions, leading to thrombosis of the small subcutaneous vessels and necrosis of the overlying skin. It is believed that the occurrence of the disease in women is underreported and may be unrecognised by some clinicians. Fournier's gangrene is a life-threatening condition, constituting an urological emergency. Many patients with Fournier's gangrene have medical or surgical conditions, which are predisposing factors to this disease or its more severe or fatal course. These comprise diabetes mellitus, hypertension, alcoholism and advanced age. Recent reports in the literature point to changes in the epidemiology of FG, comprising an increasing age of patients. Several authors reported that the mean age of FG patients is at present 53-55 years. Prognosis in FG patients is based on FGSI (Fournier's gangrene severity index) score. Despite the progress in medical care for FG patients, the mortality rate reported in the literature remains high--most often 20-40%, but ranges from 4% to 80%. The most common isolates cultured from FG lesions are both Gram-positive and Gram-negative, as well as strictly anaerobic bacteria. Recently community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) has emerged as an etiological agent of FG with severe clinical course and even fulminant sepsis. Rarely FG may have a fungal etiology, being caused by yeast-like fungi Candida spp. or by moulds. Antibiotics should be administered parenterally and in doses high enough to reach an effective concentration in the infected tissues.
authors.forename: Marta
authors.initials: M
authors.lastname: Wróblewska
authors.forename: Bolesław
authors.initials: B
authors.lastname: Kuzaka
authors.forename: Tomasz
authors.initials: T
authors.lastname: Borkowski
authors.forename: Piotr
authors.initials: P
authors.lastname: Kuzaka
authors.forename: Dariusz
authors.initials: D
authors.lastname: Kawecki
authors.forename: Piotr
authors.initials: P
authors.lastname: Radziszewski
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D018934:Fournier Gangrene / Q000188:drug therapy / Q000382:microbiology* / Q000473:pathology / Q000601:surgery; D006801:Humans; D012307:Risk Factors
chemical_list: D000900:Anti-Bacterial Agents